ArticleJournal of neurovirology2020

Early reduction of the splicing factor2/alternative splicing factor: a cellular inhibitor of the JC polyomavirus in natalizumab-treated MS patients long before developing progressive multifocal leukoencephalopathy.

Claudia Piu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.